Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Mild to Moderate Alzheimer Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00455000
What this trial is testing

A Phase I, Single IV Dose Of PF-04360365 In Adults With Mild To Moderate Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Pfizer 37
Testing effectiveness (Phase 2)Study completedNCT03656042
What this trial is testing

To Evaluate the Efficacy and Safety/Tolerability Profiles of G-CSF in Subjects With Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Chang Gung Memorial Hospital 21
Not applicableStudy completedNCT02256306
What this trial is testing

The PLasma for Alzheimer SymptoM Amelioration (PLASMA) Study

Who this might be right for
Mild-To-Moderate Alzheimer's DiseaseAlzheimer's Disease
Stanford University 18
Post-approval studies (Phase 4)Study completedNCT00551161
What this trial is testing

Magnetic Resonance Spectroscopy Study of Memantine in Alzheimer's Disease

Who this might be right for
Alzheimer Disease
Northwell Health 12
Large-scale testing (Phase 3)Study completedNCT02006641
What this trial is testing

Idalopirdine in Patients With Mild-moderate Alzheimer's Disease Treated With Donepezil

Who this might be right for
Alzheimer's Disease
H. Lundbeck A/S 858
Large-scale testing (Phase 3)Study completedNCT00151502
What this trial is testing

To Evaluate the Safety and Effectiveness of Atorvastatin Plus a Cholinesterase Inhibitor in AD Patients.

Who this might be right for
Alzheimer's Disease
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 600
Large-scale testing (Phase 3)Study completedNCT02006654
What this trial is testing

Study of Idalopirdine in Patients With Mild - Moderate Alzheimer's Disease Treated With an Acetylcholinesterase Inhibitor

Who this might be right for
Alzheimer's Disease
H. Lundbeck A/S 734
Testing effectiveness (Phase 2)Study completedNCT00380302
What this trial is testing

Activity of AVE1625 in Mild to Moderate Alzheimer's Patients.

Who this might be right for
Alzheimer Disease
Sanofi 162
Testing effectiveness (Phase 2)Active Not RecruitingNCT05834296
What this trial is testing

Study in Subjects With Mild-to-Moderate Alzheimer's Dementia

Who this might be right for
Alzheimer Disease
Alzamend Neuro, Inc. 30
Early research (Phase 1)Study completedNCT01908010
What this trial is testing

Safety, Tolerability, and Pharmacokinetics of ABT-354 in Subjects With Mild-to-Moderate Alzheimer's Disease on Stable Doses of Acetylcholinesterase Inhibitors

Who this might be right for
Alzheimer's Disease
AbbVie 20
Testing effectiveness (Phase 2)Study completedNCT01254773
What this trial is testing

Amyloid Imaging And Safety Study Of Subcutaneous Bapineuzumab In Subjects With Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
JANSSEN Alzheimer Immunotherapy Research & Development, LLC 146
Testing effectiveness (Phase 2)Study completedNCT01039701
What this trial is testing

4 Week, Safety and Tolerability Study in Patients With Mild to Moderate Alzheimer's Disease

Who this might be right for
Mild to Moderate Alzheimer's Disease
AstraZeneca 99
Large-scale testing (Phase 3)Ended earlyNCT05026177
What this trial is testing

Simufilam 50 mg or 100 mg for Mild-to-Moderate Alzheimer's Disease

Who this might be right for
Alzheimer Disease
Cassava Sciences, Inc. 1,125
Testing effectiveness (Phase 2)Study completedNCT00151333
What this trial is testing

Study Evaluating SRA-333 in Mild to Moderate Alzheimer's Disease (AD)

Who this might be right for
Alzheimer's Disease
Wyeth is now a wholly owned subsidiary of Pfizer 16
Testing effectiveness (Phase 2)Ended earlyNCT00809510
What this trial is testing

The Long-term Safety of ABT-089 for Subjects With Mild-to-moderate Alzheimer's Disease Who Participated in the M06-876 Study

Who this might be right for
Alzheimer's Disease
Abbott 63
Not applicableUnknownNCT02778581
What this trial is testing

Study to Evaluate the Effect of a Vegetal Oil on Cognitive Impairment

Who this might be right for
Cognitive ImpairmentsAlzheimer Disease
Team Foods Colombia S.A. 110
Not applicableLooking for participantsNCT06584357
What this trial is testing

Development of a Database to Investigate Digital and Blood-Based Biomarkers and Their Relationship to Tau and Amyloid PET Imaging in Older Participants Who Are Cognitively Normal (CN), Have Mild Cognitive Impairment (MCI), or Have Mild-to-Moderate AD Dementia

Who this might be right for
Mild Cognitive ImpairmentAlzheimer's DiseaseAlzheimer's Disease, Early Onset+3 more
GAP Innovations, PBC 1,200
Testing effectiveness (Phase 2)Study completedNCT00151398
What this trial is testing

Study Evaluating Lecozotan SR in Mild to Moderate Alzheimer's Disease (AD)

Who this might be right for
Alzheimer Disease
Wyeth is now a wholly owned subsidiary of Pfizer 229
Testing effectiveness (Phase 2)Study completedNCT00930059
What this trial is testing

PF-04447943 Compared To Placebo In Subjects With Mild To Moderate Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Pfizer 191
Large-scale testing (Phase 3)Study completedNCT01689246
What this trial is testing

Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
TauRx Therapeutics Ltd 891
Next Page